IPRO Awarded Measure & Instrument Development and Support (MIDS) Umbrella Contract
LAKE SUCCESS, N.Y., Aug. 28, 2018 /PRNewswire/ -- IPRO is the recipient of a 10-year federal healthcare quality measurement contract that will permit the organization to bid on individual task orders developed by the U.S. Centers for Medicare & Medicaid Services.
The Measure and Instrument Development and Support (MIDS) contract is a major, multiple-award Indefinite Delivery, Indefinite Quality (IDIQ) contract that pre-qualifies a select group of entities to bid on individual task orders as they arise. The MIDS contract supports development of outcome, process, cost and composite quality measures "suitable for endorsement by a consensus endorsement entity" addressing numerous sites of care including psychiatric hospitals, nursing homes, home health agencies, accountable care organizations, hospice programs, rehabilitation facilities and cancer hospitals. The award has a celling of $1.6 billion over the first five years of the contract.
"We're very pleased and excited to have been selected as a MIDS IDIQ contract holder and we look forward to bidding on future Task Orders addressing quality measurement in myriad settings to be issued over the next ten years," according to IPRO Chief Executive Theodore O. Will.
Among the 31 IDIQ contract awardees announced this week are such industry leaders as The Rand Corporation, The Lewin Group, General Dynamics Information and Mathematica Policy Research, Inc.
IPRO is a national, not-for-profit healthcare organization that works with government agencies, providers and consumers to implement innovative programs that bring policy ideas to life. IPRO does this by making creative use of clinical expertise, emerging technology, data solutions, and our diverse marketplace experience to make the healthcare system work better. Incorporated in 1983, IPRO is one of the nation's largest and most experienced healthcare quality improvement organizations. IPRO works in partnership with clients to achieve their goals of improved, equitable, and cost-effective healthcare.